Skip to Content

970 (Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base))

Pill with imprint 970 is Orange, Round and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 8 mg (base) / 2 mg (base). It is supplied by Sun Pharmaceutical Industries Inc..

Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 8 mg (base) / 2 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for 970

Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 8 mg (base) / 2 mg (base) 970

Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual)

Imprint
970
Strength
8 mg (base) / 2 mg (base)
Color
Orange
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Narcotic analgesic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
3 - Moderate abuse potential
Labeler / Supplier
Sun Pharmaceutical Industries Inc.
National Drug Code (NDC)
62756-0970
Inactive Ingredients
lactose monohydrate, mannitol, povidone, citric acid anhydrous, sodium citrate, FD&C Yellow No. 6, butylated hydroxyanisole, magnesium stearate, acesulfame potassium, corn starch

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "970"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.